The relationship between long non-coding gene CASC21 polymorphisms and cervical cancer

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–9. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 2018;6(5):e555–e567. doi:10.1016/S2214-109X(18)30127-X.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-6.
   PubMed Web of Science ®Google Scholar
• Voltaggio L, McCluggage WG, Iding JS, Martin B, Longacre TA, Ronnett BM. A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas. Mod Pathol. 2020;33(5):944–952. doi:10.1038/s41379-019-0437-z.
   PubMed Web of Science ®Google Scholar
• Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229–232. doi:10.1016/j.jnma.2020.03.002.
   PubMed Web of Science ®Google Scholar
• Ramachandran D, Dörk T. Genomic risk factors for cervical cancer. Cancers. 2021;13(20):5137. doi:10.3390/cancers13205137.
   PubMed Web of Science ®Google Scholar
• Niu F, Wang T, Li J, Yan M, Li D, Li B, Jin T. The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: a case-control study. Mol Genet Genomic Med. 2019;7(1):e00516. doi:10.1002/mgg3.516.
   PubMed Web of Science ®Google Scholar
• Farbod M, Karimi MZ, Heiranizadeh N, Seifi NS, Akbarian JBM, Jarahzadeh HM, Neamatzadeh H. Association of TNF-α -308G>A polymorphism with susceptibility to cervical cancer and breast cancer - a systematic review and meta-analysis. Klin Onkol. 2019;32(3):170–180. doi:10.14735/amko2019170.
   PubMedGoogle Scholar
• Liu S, Chen J, Yan Z, Dai S, Li C, Yao Y, Shi L. Polymorphisms in the CCR5 promoter associated with cervical intraepithelial neoplasia in a Chinese han population. BMC Cancer. 2019;19(1):525. doi:10.1186/s12885-019-5738-6.
   PubMedGoogle Scholar
• Isakova J, Vinnikov D, Bukuev N, Talaibekova E, Aldasheva N: Capital TE, ER C. Cyrillic53 codon 72 polymorphism and human papilloma virus-associated cervical cancer in Kyrgyz women. Asian Pac J Cancer Prev. 2019;20(4):1057–1062. doi:10.31557/APJCP.2019.20.4.1057.
   PubMedGoogle Scholar
• Li W, Qi Y, Cui X, Huo Q, Zhu L, Zhang A, Tan M, Hong Q, Yang Y, Zhang H, et al. Characteristic of HPV integration in the genome and transcriptome of cervical cancer tissues. Biomed Res Int. 2018;2018:1–7. doi:10.1155/2018/6242173.
   Web of Science ®Google Scholar
• Li N, Cui Z, Huang D, Gao M, Li S, Song M, Wang Y, Tong L, Yin Z. Association of LINC00673 rs11655237 polymorphism with cancer susceptibility: a meta-analysis based on 23,478 subjects. Genomics. 2020;112(6):4148–4154. doi:10.1016/j.ygeno.2020.07.015.
   PubMed Web of Science ®Google Scholar
• Wang Y, Luo T. LINC00673 rs11655237 polymorphism is associated with increased risk of cervical cancer in a Chinese population. Cancer Control. 2018;25(1):1073274818803942. doi:10.1177/1073274818803942.
   Web of Science ®Google Scholar
• Zhong Q, Lu M, Yuan W, Cui Y, Ouyang H, Fan Y, Wang Z, Wu C, Qiao J, Hang J. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. J Transl Med. 2021;19(1):58. doi:10.1186/s12967-021-02705-9.
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet. 2009;41(10):1122–1126. doi:10.1038/ng.448.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng X, Lu H, Ji H, Zhao E, Li Y. Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects. Oncotarget. 2016;7(42):68002–68011. doi:10.18632/oncotarget.12009.
   PubMedGoogle Scholar
• Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504–507. doi:10.1038/ng.586.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bian Y, Zhu Y, Wan L, Kong L, Hu J, Yang M, Li L, Liu B, Qian X. Integrative analysis and validation of dysregulated long non-coding RNAs in colon cancer. J Cell Mol Med. 2020;24(4):2610–2621. doi:10.1111/jcmm.14974.
   PubMed Web of Science ®Google Scholar
• Gong T, Li Y, Feng L, Fang M, Dai G, Huang X, Yang Y, Liu S. CASC21, a FOXP1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6. Aging. 2020;12(12):12086–12106. doi:10.18632/aging.103376.
   PubMedGoogle Scholar
• Hu QL, Xu ZP, Lan YF, Li B. Li B: miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer. Kaohsiung J Med Sci. 2020;36(5):328–335. doi:10.1002/kjm2.12181.
   PubMed Web of Science ®Google Scholar
• Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol. 2008;109(1):53–58. doi:10.1016/j.ygyno.2007.12.028.
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Jenabi E. The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25(3):232–238. doi:10.1097/CEJ.0000000000000164.
   PubMed Web of Science ®Google Scholar
• Charkhchi P, Schabath MB, Carlos RC. Breast, cervical, and colorectal cancer screening adherence: effect of low body mass index in women. J Women Health. 2020;29(7):996–1006. doi:10.1089/jwh.2019.7739.
   PubMed Web of Science ®Google Scholar
• Clark LH, Jackson AL, Soo AE, Orrey DC, Gehrig PA, Kim KH. Extremes in body mass index affect overall survival in women with cervical cancer. Gynecol Oncol. 2016;141(3):497–500. doi:10.1016/j.ygyno.2016.03.035.
   PubMed Web of Science ®Google Scholar
• Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, et al. Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer. J Clin Oncol. 2018;36(12):1184–1191. doi:10.1200/JCO.2017.75.3442.
   PubMed Web of Science ®Google Scholar
• Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, Bosch FX, de Sanjosé S, Dillner J, Gram IT, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer. 2014;135(2):453–466. doi:10.1002/ijc.28666.
   PubMed Web of Science ®Google Scholar
• Mayadev J, Li CS, Lim J, Valicenti R, Alvarez EA. Alcohol abuse decreases pelvic control and survival in cervical cancer: an opportunity of lifestyle intervention for outcome improvement. Am J Clin Oncol. 2017;40(5):451–457. doi:10.1097/COC.0000000000000187.
   PubMed Web of Science ®Google Scholar
• Stumbar SE, Stevens M, Feld Z. Cervical cancer and its precursors: a preventative approach to screening, diagnosis, and management. Prim Care. 2019;46(1):117–134. doi:10.1016/j.pop.2018.10.011.
   PubMed Web of Science ®Google Scholar
• Oeth P, Del Mistro G, Marnellos G, Shi T, van den Boom D. Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY). Methods Mol Biol. 2009;578:307–343.
   PubMedGoogle Scholar
• Ellis JA, Ong B. The MassARRAY(®) system for targeted SNP genotyping. Methods Mol Biol (Clifton, NJ). 2017;1492:77–94.
   PubMedGoogle Scholar
• Liu J, Yang Y, Li H, Liu Y, Sun Y, Wu J, Xiong Z, Jin T. IL1R2 polymorphisms are associated with an increased risk of esophageal cancer. Curr Mol Med. 2020;20(5):379–387. doi:10.2174/1566524019666191025091204.
   PubMed Web of Science ®Google Scholar